Literature DB >> 15274023

Mining the human cerebrospinal fluid proteome by immunodepletion and shotgun mass spectrometry.

Giuseppina Maccarrone1, Dale Milfay, Isabel Birg, Marcus Rosenhagen, Florian Holsboer, Rudolf Grimm, Jerome Bailey, Nina Zolotarjova, Christoph W Turck.   

Abstract

We have analyzed the proteome of human cerebrospinal fluid with the help of shotgun mass spectrometry. In order to identify low-abundant proteins in these fluids, we have found it necessary to remove the abundant protein components from the mixture. Immunodepletion of the abundant proteins has allowed us to identify more than 100 proteins in cerebrospinal fluids from a patient suffering from normal pressure hydrocephalus. The identified proteins belong to a variety of different classes ranging from serum proteins to intracellular mediators that are involved in signal transduction and transcription. This work establishes a platform for future studies aimed at the comparative proteome analysis of cerebrospinal fluids from different groups of patients suffering from various psychiatric and neurological disorders.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15274023     DOI: 10.1002/elps.200305909

Source DB:  PubMed          Journal:  Electrophoresis        ISSN: 0173-0835            Impact factor:   3.535


  20 in total

1.  Cerebrospinal fluid biomarkers for major depression confirm relevance of associated pathophysiology.

Authors:  Claudia Ditzen; Ning Tang; Archana M Jastorff; Larysa Teplytska; Alexander Yassouridis; Giuseppina Maccarrone; Manfred Uhr; Thomas Bronisch; Christine A Miller; Florian Holsboer; Christoph W Turck
Journal:  Neuropsychopharmacology       Date:  2011-12-14       Impact factor: 7.853

2.  Age-dependent changes in the cerebrospinal fluid proteome by slow off-rate modified aptamer array.

Authors:  Geoffrey S Baird; Sally K Nelson; Tracy R Keeney; Alex Stewart; Stephen Williams; Stephan Kraemer; Elaine R Peskind; Thomas J Montine
Journal:  Am J Pathol       Date:  2011-11-26       Impact factor: 4.307

Review 3.  Proteomics of human neurodegenerative diseases.

Authors:  Jing Zhang; C Dirk Keene; Catherine Pan; Kathleen S Montine; Thomas J Montine
Journal:  J Neuropathol Exp Neurol       Date:  2008-10       Impact factor: 3.685

4.  Protein changes in immunodepleted cerebrospinal fluid from a transgenic mouse model of Alexander disease detected using mass spectrometry.

Authors:  Robert Cunningham; Paige Jany; Albee Messing; Lingjun Li
Journal:  J Proteome Res       Date:  2013-01-11       Impact factor: 4.466

5.  Mass Spectrometry-based Proteomics and Peptidomics for Systems Biology and Biomarker Discovery.

Authors:  Robert Cunningham; Di Ma; Lingjun Li
Journal:  Front Biol (Beijing)       Date:  2012-08-01

6.  Alterations in protein regulators of neurodevelopment in the cerebrospinal fluid of infants with posthemorrhagic hydrocephalus of prematurity.

Authors:  Diego M Morales; R Reid Townsend; James P Malone; Carissa A Ewersmann; Elizabeth M Macy; Terrie E Inder; David D Limbrick
Journal:  Mol Cell Proteomics       Date:  2011-12-20       Impact factor: 5.911

7.  The development of an integrated platform to identify breast cancer glycoproteome changes in human serum.

Authors:  Zhi Zeng; Marina Hincapie; Brian B Haab; Samir Hanash; Sharon J Pitteri; Steven Kluck; Jason M Hogan; Jacob Kennedy; William S Hancock
Journal:  J Chromatogr A       Date:  2009-09-16       Impact factor: 4.759

8.  Ubiquitin fusion degradation protein 1 as a blood marker for the early diagnosis of ischemic stroke.

Authors:  Laure Allard; Natacha Turck; Pierre R Burkhard; Nadia Walter; Anna Rosell; Marianne Gex-Fabry; Denis F Hochstrasser; Joan Montaner; Jean-Charles Sanchez
Journal:  Biomark Insights       Date:  2007-04-19

9.  Establishing the proteome of normal human cerebrospinal fluid.

Authors:  Steven E Schutzer; Tao Liu; Benjamin H Natelson; Thomas E Angel; Athena A Schepmoes; Samuel O Purvine; Kim K Hixson; Mary S Lipton; David G Camp; Patricia K Coyle; Richard D Smith; Jonas Bergquist
Journal:  PLoS One       Date:  2010-06-11       Impact factor: 3.240

Review 10.  Biomarker discovery in neurodegenerative diseases: a proteomic approach.

Authors:  Min Shi; W Michael Caudle; Jing Zhang
Journal:  Neurobiol Dis       Date:  2008-09-26       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.